Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Accounts Payable
$1.54M
Quarterly · Period ending: · USD
LCTX Accounts Payable
Latest reported$1.54Mperiod ending
Latest reported$1.54Mperiod ending
LCTX Quarterly Accounts Payable ($200.00K → $1.54M)
Quarterly accounts payable
High-resolution chart · PNG
LCTX accounts payable history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Accounts Payable (USD) |
|---|---|
| 1,536,000 | |
| 5,567,000 | |
| 2,341,000 | |
| 1,520,000 | |
| 1,497,000 | |
| 1,995,000 | |
| 1,174,000 | |
| 1,599,000 | |
| 2,388,000 | |
| 2,211,000 | |
| 2,050,000 | |
| 2,430,000 | |
| 2,187,000 | |
| 3,001,000 | |
| 2,393,000 | |
| 2,865,000 | |
| 2,589,000 | |
| 2,956,000 | |
| 3,543,000 | |
| 3,457,000 | |
| 2,720,000 | |
| 2,797,000 | |
| 2,611,000 | |
| 3,155,000 | |
| 3,424,000 | |
| 3,519,000 | |
| 2,427,000 | |
| 1,909,000 | |
| 1,978,000 | |
| 1,379,000 | |
| 2,359,000 | |
| 717,000 | |
| 1,181,000 | |
| 703,000 | |
| 938,000 | |
| 508,000 | |
| 752,000 | |
| 1,064,000 | |
| 1,593,000 | |
| 1,687,000 | |
| 1,758,000 | |
| 4,546,000 | |
| 2,798,000 | |
| 1,934,000 | |
| 2,661,000 | |
| 2,707,437 | |
| 2,297,000 | |
| 2,423,400 | |
| 1,880,095 | |
| 2,527,330 | |
| 3,434,748 | |
| 2,202,410 | |
| 1,687,529 | |
| 1,460,864 | |
| 1,168,077 | |
| 708,961 | |
| 890,875 | |
| 602,464 | |
| 1,118,112 | |
| 982,508 | |
| 1,466,525 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 958,537 | |
| 623,065 | |
| 590,000 | |
| 480,374 | |
| 442,162 | |
| 433,287 | |
| 553,358 | |
| 431,713 | |
| 315,440 | |
| 278,876 | |
| 296,614 | |
| 566,597 | |
| 235,210 | |
| 266,578 | |
| 267,893 | |
| 275,256 | |
| 131,093 | |
| 147,811 | |
| 185,190 | |
| 408,891 | |
| 249,701 | |
| 317,479 | |
| 428,753 | |
| 358,000 | |
| 278,037 | |
| 355,641 | |
| 189,643 | |
| 309,347 | |
| 102,232 |